Top compounds associated with response to CT45A7


Feature Type Standardized
Nominal ANOVA
mRNA quizartinib CTRPv2 pan-cancer AAC -0.011 0.8
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.011 0.8
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.01 0.8
mRNA triptolide CTRPv2 pan-cancer AAC 0.01 0.8
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.0093 0.8
mRNA SKI-II CTRPv2 pan-cancer AAC -0.011 0.8
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0092 0.8
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA Ko-143 CTRPv2 pan-cancer AAC -0.0099 0.8
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.01 0.8
Download CSV